Use our tool to learn about selected attributes of the Norditropin ® pen and a range of other daily and weekly growth hormone therapy devices.

Norditropin ® (somatropin) injection is indicated for use in children with growth failure or short stature due to certain growth-related disorders and adults with growth hormone deficiency. Please scroll down to see full indications, usage, and Important Safety Information. Please see Instructions for Use for complete instructions.

Discover which Norditropin® FlexPro® pen to prescribe to your patient by inputting their daily dose. Read Important Safety and Prescribing Info. Growth-Related Disorders

Norditropin ® FlexPro ® pens are available in 4 strengths with fine dosing increments to help you give patients precisely the dose they need. Already know your patient’s daily dose? Find out which FlexPro ® pens they can use with our pen selector.

Find the FlexPro® pen injection instructions and information on how to store Norditropin®. Read Important Safety and Prescribing Info.

Learn more about your Norditropin® FlexPro® pen by choosing your prescribed dosage, 5mg, 10mg, 15mg, or 30mg. Read important safety and prescribing information.

Instructions for delivering the dosage are provided in the PATIENT INFORMATION and INSTRUCTIONS FOR USE leaflets enclosed with the NORDITROPIN FlexPro prefilled pen. Individualize dosage for each patient based on the growth response. Divide the calculated weekly NORDITROPIN dosage into equal doses given either 6, or 7 days per week.

Your Norditropin FlexPro pen is a pre-filled growth hormone pen. Norditropin FlexPro contains 5 mg human growth hormone solution and delivers doses from 0.025 mg to 2.0 mg, in increments of 0.025 mg. Norditropin FlexPro is designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.

Norditropin FlexPro pens are for use by 1 person only. Do not share your Norditropin pen and needles with another person. You may give another person an infection or get an infection from them. Dosing information. Norditropin should be administered subcutaneously (under the skin). Pediatric GHD: 0.024 to 0.034 mg/kg/day, 6 to 7 times a week

Norditropin ® (somatropin) injection is indicated for the treatment of pediatric patients with: growth failure due to inadequate secretion of endogenous growth hormone (GH) short stature associated with Noonan syndrome,